Comparative evaluation of serum markers in pulmonary sarcoidosis

Chest

Volumn 137, Issue 6, 2010, Pages 1391-1397

  Miyoshi, Seigo ^a   Hamada, Hironobu ^a   Kadowaki, Toru ^a   Hamaguchi, Naohiko ^a   Ito, Ryoji ^a   Irifune, Kazunori ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOPROTEIN; GLYCOPROTEIN KL 6; LYSOZYME; SERUM AMYLOID A; SOLUBLE INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG INFILTRATE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SARCOIDOSIS; THORAX RADIOGRAPHY;

EID: 77953307608     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1975     Document Type: Article

References (29)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-173.
2. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J. 1998;12(3):716-738.
3. Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest. 1996;109(5):1276-1282. (Pubitemid 26145667)
4. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003;124(1):186-195.
5. Selroos OBN. Biochemical markers in sarcoidosis. Crit Rev Clin Lab Sci. 1986;24(3):185-216.
6. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PGH, Drent M. Potential usefulness of infl ammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem. 2003;49(9):1510-1517.
7. Salazar A, Maña J, Fiol C, et al. Infl uence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis. Atherosclerosis. 2000;152(2):497-502.
8. Tomita H, Sato S, Matsuda R, et al. Serum lysozyme levels and clinical features of sarcoidosis. Lung. 1999;177(3):161-167.
9. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J. 1991;4(1):94-102.
10. Rossi GA, Sacco O, Cosulich E, Risso A, Balbi B, Ravazzoni C. Helper T-lymphocytes in pulmonary sarcoidosis. Functional analysis of a lung T-cell subpopulation in patients with active disease. Am Rev Respir Dis. 1986;133(6):1086-1090. (Pubitemid 16090017)
11. Belli F, Capra A, Moraiti A, Rossi S, Rossi P. Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases. Int J Immunopathol Pharmacol. 2000;13(2):61-67. (Pubitemid 30614230)
12. Zheng L, Teschler H, Guzman J, Hübner K, Striz I, Costabel U. Alveolar macrophage TNF- a release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med. 1995;152(3):1061-1066.
13. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med. 1999;37(4):381-388.
14. Vink A, Uyttenhove C, Wauters P, Van Snick J. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor. Eur J Immunol. 1990;20(1):1-6. (Pubitemid 20087021)
15. Kumar A, Moreau JL, Gibert M, Thèze J. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines. J Immunol. 1987;139(11):3680-3684. (Pubitemid 18013641)
16. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest. 1989;96(1):68-73. (Pubitemid 19176416)
17. Hamada H, Kohno N, Akiyama M, Hiwada K. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest. 1992;101(3):858-860.
18. Ohnishi H, Yokoyama A, Yasuhara Y, et al. Circulating KL-6 levels in patients with drug induced pneumonitis. Thorax. 2003;58(10):872-875.
19. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002;165(3):378-381. (Pubitemid 34118512)
20. Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Müller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med. 1997;156(5):1586-1592. (Pubitemid 27505529)
21. Prior C, Barbee RA, Evans PM, et al. Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other infl ammatory markers in pulmonary sarcoidosis. Eur Respir J. 1990;3(10):1146-1154.
22. Janssen R, Sato H, Grutters JC, et al. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest. 2003;124(6):2119-2125.
23. Verstraeten A, Demedts M, Verwilghen J, et al. Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis. Chest. 1990;98(3):560-567.
24. Keogh BA, Hunninghake GW, Line BR, Crystal RG. The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis. 1983;128(2):256-265.
25. Carreiro G, Rottoli P, Rottoli L, Perari MG. Alveolar lymphocytes in the follow-up of sarcoidosis. Allergol Immunopathol (Madr). 1984;12(5):377-382.
26. Ina Y, Takada K, Sato T, Yamamoto M, Noda M, Morishita M. Soluble interleukin 2 receptors in patients with sarcoidosis. Possible origin. Chest. 1992;102(4):1128-1133.
27. Okada M, Takahashi H, Nukiwa T, et al. Correlative analysis of longitudinal changes in bronchoalveolar lavage, 67 gallium scanning, serum angiotensin-converting enzyme activity, chest X-ray, and pulmonary function tests in pulmonary sarcoidosis. Jpn J Med. 1987;26(3):360-367.
28. Tsutsumi T, Nagai S, Imai K, Setoyama Y, Uchiyama T, Izumi T. Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fi brosis. Sarcoidosis. 1994;11(2):102-109.
29. Westall GP, Stirling RG, Cullinan P, et al. Interstitial Lung Disease. 4th ed. Hamilton, London, England : BC Decker; 2003:332-386.